Allen Ehrlich

Ehrlich Consulting Group, Inc. specializes in commercial product marketing, marketing strategy/tactics, sales/sales operations and distribution for companies in the medical device industry. ECG provides a hands-on, insight-driven, results-oriented approach using best practices, functional and industry experience.

Allen Ehrlich, CEO of Ehrlich Consulting Group (ECG), Inc., is an accomplished international marketing and sales leader with over 20+ years in the medical device industry. His passion is commercializing products, listening to the voice of the customer and leading marketing and sales processes. He founded the independent consultancy in December 2012.

He holds an MBA in Marketing and a BS in Accounting from Indiana University, Read more

Ehrlich Consulting Group, Inc. specializes in commercial product marketing, marketing strategy/tactics, sales/sales operations and distribution for companies in the medical device industry. ECG provides a hands-on, insight-driven, results-oriented approach using best practices, functional and industry experience.

Allen Ehrlich, CEO of Ehrlich Consulting Group (ECG), Inc., is an accomplished international marketing and sales leader with over 20+ years in the medical device industry. His passion is commercializing products, listening to the voice of the customer and leading marketing and sales processes. He founded the independent consultancy in December 2012.

He holds an MBA in Marketing and a BS in Accounting from Indiana University, Kelley School of Business in Bloomington, Indiana. He also attended Tilburg University to study international business.

Sample Projects include:
• Developed a commercial readiness plan for a company launching disruptive technology into the wound care dressing ($200 MM) and surgical incise drape markets ($130 MM).
• Created a key opinion leader/hospital targeting plan capable of building awareness for new wound dressing products that will reduce hospital acquired infections (HAIs). Report included research process, selection criteria, and recommendations.
• Provided market insights, created product requirements, and conducted usability studies for a company developing an alternative device to treat respiratory disorders. ($3B)
• Negotiation and distribution of a respiratory medication nebulizer into the hospital ($130 MM) and home-care markets ($60 MM).

Every engagement is unique. The scope is agreed with the client during the initial consultation.

Medical Device, Diagnostic and Life Science Companies. Specific Areas include:

• Respiratory
• Diagnostics
• Wound Care
• Surgical Products
• Disposables
• ENT

Medical Device, Diagnostic and Life Science Companies. Specific Areas include:

• Respiratory
• Diagnostics
• Wound Care
• Surgical Products
• Disposables
• ENT